ArticleBlood2020
The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients.
Steven P Treon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
204 papers cite itlatest 60 shown
this paperpooled ittrialcites it